UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMALGAMATED BANK | 2,772 | $39 | 0.00% |
| BlackRock Inc. | 1,197,647 | $16,779,035 | 0.00% |
| Allspring Global Investments Holdings, LLC | 3,764 | $52,733 | 0.00% |
| Bank of New York Mellon Corp | 57,806 | $809,862 | 0.00% |
| Cutler Group LLC / CA | 1,800 | $1 | 0.00% |
| Citadel Advisors | 27,500 | $385,275 | 0.00% |
| Citadel Advisors | 8,100 | $113,481 | 0.00% |
| Citadel Advisors | 6,996 | $98,014 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 13,900 | $194,739 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 18,500 | $259,185 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 20,175 | $282,652 | 0.00% |
| VANGUARD GROUP INC | 111,834 | $1,566,795 | 0.00% |
| Daiwa Securities Group Inc. | 48 | $1 | 0.00% |
| SIMPLEX TRADING, LLC | 3,150 | $44 | 0.00% |
| Blue Trust, Inc. | 1,567 | $16 | 0.00% |
| SIGNATUREFD, LLC | 80 | $1,121 | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 11,288 | $158,145 | 0.00% |
| D. E. Shaw & Co., Inc. | 33,633 | $471,198 | 0.00% |
| FEDERATED HERMES, INC. | 13,130 | $183,951 | 0.00% |
| ROYAL BANK OF CANADA | 17,016 | $239,000 | 0.00% |
External links
This page lists UROGEN PHARMA LTD's shareholders in Q3 2023. To view UROGEN PHARMA LTD's shareholder history, click here.